Patent case: Novartis AG vs. Pharmathen Global B.V., Netherlands

search-result-placeholder.jpg

In the present preliminary case a cross-border injunction was ordered by the provisions judge. He came to this conclusion because he found the product to be infringing (in contrast to a preliminary decision of the Greek court) and he found that the Dutch-based Pharmathen company was controlling the other companies in the group.

Case date: 19 July 2022

Case number: C/09/625801 / KG ZA 22-201

Court: Provisions Judge of the District Court of The Hague

A full summary of this case has been published on Kluwer IP Law.

Comments (0)
Your email address will not be published.
Leave a Comment
Your email address will not be published.
Clear all
Become a contributor!
Interested in contributing? Submit your proposal for a blog post now and become a part of our legal community! Contact Editorial Guidelines
Image
AI Assistant on Kluwer IP Law's Manual IP
Image
Whitepaper

Book Ad List

Books
book1
Vissers Annotated European Patent Convention 2024 Edition
Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge
€105.00
AIPPI
Experimental Use and Bolar Exemptions
David Gilat, Charles A. Boulakia, Daphné Derouane & Ralph Nack
€190.00
book2
Annotated PCT
Malte Köllner
€160.00